Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 20, 2007
[Pathophysiology of depression]Akira Tanabe, Soichiro Nomura
Comprehensive Psychiatry|December 13, 2003
Cincinnati criteria for mixed mania and suicidality in patients with acute maniaTetsuya Sato, Ronald Bottlender, Akira Tanabe, et al.
Psychopharmacology|July 2, 2005
Simplifying psychotropic medication regimen into a single night dosage and reducing the dose for patients with chronic schizophreniaTakefumi Suzuki, Hiroyuki Uchida, Hiroyoshi Takeuchi, et al.
Human Psychopharmacology|December 1, 2009
Augmentation of atypical antipsychotics with valproic acid. An open-label study for most difficult patients with schizophreniaTakefumi Suzuki, Hiroyuki Uchida, Hiroyoshi Takeuchi, et al.
Schizophrenia Research|September 23, 2008
Novel rating scales for schizophrenia - Targeted Inventory on Problems in Schizophrenia (TIP-Sz) and Functional Assessment for Comprehensive Treatment of Schizophrenia (FACT-Sz)Takefumi Suzuki, Hiroyuki Uchida, Kensuke Nomura, et al.
Human Psychopharmacology|June 10, 2008
Effectiveness of antipsychotic polypharmacy for patients with treatment refractory schizophrenia: an open-label trial of olanzapine plus risperidone for those who failed to respond to a sequential treatment with olanzapine, quetiapine and risperidoneTakefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe, et al.
The International Journal of Neuropsychopharmacology|January 27, 2004
Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophreniaTakefumi Suzuki, Hiroyuki Uchida, Kenji F Tanaka, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 2, 2008
Effects of age and age of onset on prescribed antipsychotic dose in schizophrenia spectrum disorders: a survey of 1,418 patients in JapanHiroyuki Uchida, Takefumi Suzuki, David C Mamo, et al.
International Clinical Psychopharmacology|October 23, 2003
Reducing the dose of antipsychotic medications for those who had been treated with high-dose antipsychotic polypharmacy: an open study of dose reduction for chronic schizophreniaTakefumi Suzuki, Hiroyuki Uchida, Kenji F Tanaka, et al.
Psychopharmacology|August 19, 2007
How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical settingTakefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe, et al.
Pageof 2